Tiny ultrasound chip tracks blood pressure under the skin
A new, implantable, ultrasound-based blood pressure monitoring system represents a promising alternative to conventional tools for continuous, unobtrusive blood pressure measurement.
Accurate, continuous blood pressure (BP) monitoring is essential for preventing cardiovascular events, yet conventional cuffs and wearable sensors often suffer from discomfort, motion interference and poor alignment. This study, led by researchers from the University of California, Berkeley (CA, USA), demonstrates a minimally invasive, subcutaneously implanted ultrasonic device capable of capturing real-time arterial diameter changes to derive precise BP values.
Using a compact array of aluminum-nitride piezoelectric micromachined ultrasonic transducers (PMUTs), the system detects echo signals from both arterial walls to reconstruct full BP waveforms. In vitro and in vivo tests – including implantation in an ambulatory sheep – show that the device achieves clinically acceptable errors of less than 3 mmHg. The findings highlight a promising path toward long-term, comfortable BP monitoring for hypertension management.
Hypertension remains one of the world’s leading causes of heart disease, stroke and premature mortality. Although regular blood pressure tracking can significantly reduce cardiovascular risks, traditional cuff-based measurements disrupt daily activity and are unsuitable for continuous monitoring. Alternatives such as photoplethysmography and wearable ultrasound patches attempt to address these limitations but often struggle with shallow penetration depth, dependence on gels and significant sensitivity to misalignment or motion. Implantable sensors have emerged as a potential solution, yet many require intrusive placement inside arteries or suffer from foreign-body reactions at the interface. Due to these challenges, there is a need for deeper research on reliable, non-intrusive implantable systems for continuous BP assessment.
Researchers from the University of California, Berkeley, and collaborating institutions report a new implantable ultrasound-based blood pressure monitoring system in a paper published in Microsystems & Nanoengineering on November 6, 2025. The study presents a subcutaneous device built on a 5 × 5 mm² PMUTs array that continuously measures arterial diameter changes to reconstruct BP waveforms. Through comprehensive laboratory validation and an in vivo implantation in an ambulatory sheep, the team demonstrated that the device achieves clinically reliable systolic and diastolic measurements with minimal calibration error.
The newly developed system relies on a dense 37 × 45 PMUT array fabricated using CMOS-compatible processes. Each PMUT features a 29-µm diaphragm and operates at approximately 6.5 MHz in water, enabling high axial resolution and strong echo penetration through tissue. The dual-electrode bimorph design significantly enhances acoustic output, while an optimized deep reactive ion etching process ensures high structural uniformity across the array.
Intense ultrasound enables less invasive cancer biopsies
Intense ultrasound helps release cancer biomarkers from cells to enable less invasive and more affordable cancer screening.
To derive blood pressure, the device measures the time-of-flight between ultrasound echoes reflected from the anterior and posterior arterial walls. This time interval is converted into a real-time diameter waveform, which correlates directly with blood pressure through vessel stiffness models. Bench-top tube experiments confirmed the linear relationship between diameter and pressure, and simulations revealed that wearable systems can lose up to 60% signal strength with only 1 mm of misalignment – an issue the implanted design avoids.
During in vivo testing, researchers implanted the PMUT system above the femoral artery of an adult sheep. The device successfully captured detailed pressure waveforms, including features such as the dicrotic notch, and matched gold-standard arterial line measurements within −1.2 ± 2.1 mmHg (systolic) and −2.9 ± 1.4 mmHg (diastolic). These results demonstrate that the minimally invasive design maintains stable coupling and accurate long-term performance.
“The study shows that ultrasound-based implants can achieve the stability and precision required for continuous blood pressure monitoring without the drawbacks of cuffs or fragile wearables,” summarized the corresponding author. “By capturing arterial diameter changes directly through subcutaneous sensing, the device avoids issues like gel dependence, environmental noise and misalignment. Our findings suggest that this technology could support long-term hypertension management and provide clinicians with richer cardiovascular data than periodic measurements allow.”
This implantable PMUT-based system represents a promising alternative to conventional BP monitoring tools for patients requiring continuous, unobtrusive measurement. Its stability against tissue growth, motion and environmental interference makes it particularly suitable for long-term hypertension management, early detection of cardiovascular abnormalities and integration into digital health platforms. Future advances – such as beamforming to mitigate positional shifts and data-driven analytics for individualized risk prediction – could further expand its clinical utility. Ultimately, this technology may enable preventive care strategies by providing continuous, high-fidelity cardiovascular data in real-world environments.
This article has been republished from the following materials. Material may have been edited for length and house style. For further information, please contact the cited source. Our press release publishing policy can be accessed here.